PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma
The expansion of nanotechnology for drug delivery applications has raised questions regarding the safety of nanoparticles (NPs) due to their potential for interacting at molecular and cellular levels. Although polymeric NPs for drug delivery are formulated using FDA-approved polymers such as lactide...
Main Authors: | Rana Bakhaidar, Sarah O’Neill, Zebunnissa Ramtoola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/24/9716 |
Similar Items
-
Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets
by: Rana Bakhaidar, et al.
Published: (2019-10-01) -
Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin
by: Pallavi S Badade, et al.
Published: (2016-01-01) -
Spectrophotometric Determination of the Aggregation Activity of Platelets in Platelet-Rich Plasma for Better Quality Control
by: Tetsuhiro Tsujino, et al.
Published: (2019-06-01) -
Platelet-rich plasma and platelet-rich fibrin in periodontal regeneration: A review
by: Sunil Paramel Mohan, et al.
Published: (2019-01-01) -
Prospective Evaluation of Feline Sourced Platelet-Rich Plasma Using Centrifuge-Based Systems
by: Jonathan T. Ferrari, et al.
Published: (2020-06-01)